BNGO Summary

  1. NASDAQ
  2. >
  3. BNGO
TickerBNGO
DescriptionBIONANO GENOMICS INC
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano's Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees147
Next Earnings DateAugust 4th, 2021
IV113.075232%
IV Percentile43rd
IV Rank15.66%
IV Skew-2.098393
IV Skew Percentile53rd
IV Skew SentimentNeutral
Option Volume10,524
Volume3,459,283
Price$6.12
Previous Close$5.92
52-Week High$15.69
52-Week Low$0.4735
50-Day Moving Avg.$6.59
200-Day Moving Avg.$7.82
10-Day Avg. Volume7,510,764
20-Day Avg. Volume9,579,148
30-Day Avg. Volume9,592,130
3-Month Avg. Volume18,550,746
EPS-$0.13
Outstanding Shares278,849,616
Market Capitalization$1,681,463,200
CurrencyUSD
UpdatedAugust 4th, 2021